Skip to main content
. 2018 Aug;9(4):734–740. doi: 10.21037/jgo.2018.05.01

Table 2. Response rate via mRECIST.

Response Total (n=95) Salvage-SBRT (n=46) Adjuvant-SBRT (n=49) P
Complete response 59 (62.1) 20 (43.5) 39 (79.6) 0.006
Partial response 25 (26.3) 17 (37.0) 8 (16.3)
Stable disease 6 (6.3) 5 (10.9) 1 (2.0)
Progression of disease 5 (5.3) 4 (8.7) 1 (2.0)

mRECIST, modified response evaluation criteria in solid tumors; SBRT, stereotactic body radiation therapy.